NAGE · Niagen Bioscience, Inc. · Exempt Offerings
$2.50
+0.06 (+2.46%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27
473.48K
Avg daily vol (3M)
546.87K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
17 filings
16 filers
Visit website
Investor relations